John E. Kao - 10 Jun 2026 Form 4 Insider Report for Alignment Healthcare, Inc. (ALHC)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: ALHC
Reported as of: 10 Jun 2026
Net transaction value: -$6,066,621
SEC form: 4
Accepted by SEC: 12 Jun 2026, 16:03:23 UTC
Prior SEC filing: 13 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao

Key filing fact

John E. Kao filed Form 4 for Alignment Healthcare, Inc. (ALHC) on 12 Jun 2026.

Key facts

This page summarizes John E. Kao's Form 4 filing for Alignment Healthcare, Inc. (ALHC).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 12 Jun 2026, 16:03.

Change

Previous filing in this sequence was filed on 13 May 2026.
Current net transaction value: -$6,066,621.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001222028 Primary reporting owner

KAO JOHN E

Relationship: Chief Executive Officer, Director
Address: 1100 W. TOWN & COUNTRY RD., SUITE 1600, ORANGE
Signature: /s/ Christopher J. Joyce, as Attorney-in-Fact, for John E. Kao
Signature date: 12 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ALHC transaction

Common Stock

Sale

Transaction value: $1,472,350
Shares: -74,936
Change %: -4.4%
Price: $19.65
Shares after: 1,609,830
Date: 10 Jun 2026
Ownership: See Footnote
Footnotes: F1, F2, F3, F4

ALHC transaction

Common Stock

Sale

Transaction value: $4,594,271
Shares: -223,064
Change %: -14%
Price: $20.60
Shares after: 1,386,766
Date: 10 Jun 2026
Ownership: See Footnote
Footnotes: F1, F3, F4, F5

ALHC holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 1,608,743
Date: 10 Jun 2026
Ownership: Direct
Footnotes: F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 5 footnotes

Footnote F1

Date of Rule 10b5-1 plan adoption: 11/21/2025

Footnote F2

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $19.12 to $20.11. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.

Footnote F3

Balances in column 5 reflect the transfer of 176,125 shares held directly by Mr. Kao to the JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Footnote F4

Represents securities held by JEK Trust, dated February 8, 2021, of which Mr. Kao is the trustee.

Footnote F5

The reported price in column 4 is a weighted-average price. Shares were sold in multiple transactions at a per share price ranging from $20.12 to $20.89. The reporting person undertakes to provide to Alignment Healthcare, Inc., any security holder of Alignment Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range.